Shilanski & Associates’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Shilanski & Associates's AMGN Position: Q3 2025 in Review
Shilanski & Associates increased its Amgen (AMGN) stake by 0.93% in Q3 2025, buying an estimated $2.03K and bringing the position to 759 shares worth $214K. The position accounts for 0.06% of the portfolio, ranked #105.
Shilanski & Associates first reported a position in AMGN in Q1 2021 and has held it in 18 quarters since. The position peaked at $446K in Q3 2022. 2,826 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.
- Shilanski & Associates held 759 shares of Amgen worth $214K as of Q3 2025.
- Shilanski & Associates bought 7 Amgen shares in Q3 2025, an estimated $2.03K.
- Amgen made up 0.06% of Shilanski & Associates's portfolio in Q3 2025, its #105 holding.
- Shilanski & Associates first reported a position in Amgen in Q1 2021 and has held it in 18 quarters since.
- Shilanski & Associates's Amgen position peaked at $446K in Q3 2022.
- 2,826 funds tracked by Wall St. Rank held Amgen as of Q3 2025.
Based on Shilanski & Associates's 13F filing for Q3 2025, filed 20 Oct 2025.